Autonomix showcases PoC study clinical data for pancreatic cancer pain relief.

Autonomix Medical presented new clinical data at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium showing rapid and durable pain relief in pancreatic cancer patients across all disease stages. The data highlights consistent, clinically meaningful pain reduction from Stage 2 through Stage 4 disease, including late-stage patients with limited treatment options.